CENTURY THERAPEUTICS INC (IPSC)
US15673T1007 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 52.59M | 47.32M | 84.30M | 56.40M | 27.20M | |||
| Marketable Securities | 145.52M | 125.41M | 231.20M | 166.40M | 48.50M | |||
| Other Current Assets | 7.90M | 4.26M | 4.20M | 5.30M | 3.10M | |||
| Total Current Assets | 206.01M | 176.99M | 319.70M | 228.20M | 78.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 94.11M | 92.08M | 111.70M | 69.80M | 24.80M | |||
| Investments And Advances | 46.56M | 89.10M | 51.90M | 135.90M | 1.10M | |||
| Goodwill | 4.73M | N/A | N/A | N/A | N/A | |||
| Intangibles | 33.80M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 3.40M | 2.52M | 3.20M | 3.50M | 2.10M | |||
| Total Non-Current Assets | 182.61M | 183.70M | 166.80M | 209.20M | 28.00M | |||
| TOTAL ASSETS | 388.62M | 360.69M | 486.50M | 437.40M | 106.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 6.50M | 1.00M | N/A | |||
| Accrued Expenses | 13.36M | 10.12M | 9.80M | 6.00M | 4.00M | |||
| Accounts Payable | 2.60M | 2.74M | 5.50M | 7.60M | 8.10M | |||
| Other Current Liabilities | 3.86M | 4.98M | 8.00M | 1.00M | N/A | |||
| Total Current Liabilities | 19.82M | 17.85M | 29.80M | 15.70M | 12.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 3.70M | 8.90M | 9.60M | |||
| Deferred Taxes/Income | 3.50M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 169.61M | 158.09M | 150.30M | 16.60M | 11.70M | |||
| Total Non-Current Liabilities | 173.11M | 158.09M | 154.00M | 25.40M | 21.30M | |||
| TOTAL LIABILITIES | 192.93M | 175.94M | 183.80M | 41.10M | 33.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -746.27M | -655.77M | -519.10M | -388.20M | -324.20M | |||
| Additional Paid In Capital | 941.18M | 840.41M | 824.30M | 785.00M | 217.80M | |||
| Common Shares | 9.00K | 6.00K | 0.00 | 0.00 | 179.80M | |||
| Other Shareholders' Equity | 758.00K | 108.00K | -2.50M | -700.00K | 0.00 | |||
| Shares Outstanding | 84.55M | 60.34M | 58.50M | 55.00M | 7.50M | |||
| Tangible Book Value per Share | 1.86 | 3.06 | 5.17 | 7.20 | -14.20 | |||
| Total Shareholders' Equity | 195.69M | 184.75M | 302.70M | 396.20M | 73.30M | |||
| TOTAL LIABILITIES AND EQUITY | 388.62M | 360.69M | 486.50M | 437.40M | 106.80M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.01 | 0.02 | 0.13 | |||
| Current Ratio | 10.39 | 9.92 | 10.73 | 14.54 | 6.51 | |||
| Return On Assets (ROA) | -33.42% | -37.89% | -26.91% | -21.91% | -50.17% | |||
| Return On Equity (ROE) | -66.38% | -73.98% | -43.25% | -24.18% | -73.10% | |||
All data in USD , ROIC based on taxRate of 0.21